Diagnostic Center | April 04, 2024
Evonik unveils latest global trial results MetAMINO
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
A five-day inspection was concluded successfully with no critical and no major observations raised
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
ANVISA issues CGMP to Concord Biotech’s Unit I
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
10+ emerging markets, Japan & ANZ transition in final phase
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Subscribe To Our Newsletter & Stay Updated
